Esophageal Variceal Bleeding: The Pressure Cascade Behind a GI Emergency

What It Is and Why It Matters

Esophageal varices are engorged submucosal veins in the distal esophagus that form as a decompression route when blood cannot flow normally through a cirrhotic liver. They are a direct readout of portal hypertension. When one bursts, the result is one of the true GI emergencies — a bleed that can exsanguinate a patient in minutes.

• Varices are present in roughly 50% of patients with cirrhosis, and prevalence rises with disease severity.
• Each year about 5–15% of patients with varices experience a first bleed.
• The 6-week mortality after an index variceal bleed is approximately 15–20%, and higher in decompensated (Child–Pugh C) disease.

What makes variceal bleeding uniquely lethal is that it stacks two problems: torrential blood loss and an underlying liver that cannot mount a normal coagulation or hemodynamic response. The same portal hypertension that created the varix also drives ascites, hepatic encephalopathy, and coagulopathy — so the bleeding patient is fragile before a single drop is lost. This is why variceal bleeding is managed as a coordinated resuscitation, not just an endoscopic fix.

The Pressure Cascade: Step-by-Step Pathophysiology

The disease is fundamentally about the hepatic venous pressure gradient (HVPG) — the difference between wedged (sinusoidal) and free hepatic venous pressure, normally 3–5 mmHg. The cascade unfolds in stages:

• Increased resistance: In cirrhosis, fibrosis and regenerative nodules mechanically distort sinusoids, and activated stellate cells plus reduced endothelial nitric oxide raise intrahepatic vascular resistance. This is the initiating insult.
• Splanchnic vasodilation: Systemically, excess NO and other vasodilators cause splanchnic arterial dilation, increasing portal inflow — a hyperdynamic circulation that worsens the gradient.
• Collateral formation: Once HVPG exceeds ~10 mmHg (clinically significant portal hypertension), portosystemic collaterals open. The left gastric (coronary) vein feeds the distal esophageal submucosal plexus, forming varices.
• Wall stress and rupture: By Laplace's law, wall tension ∝ (transmural pressure × radius) / wall thickness. As pressure and varix diameter rise and the wall thins, tension exceeds the breaking point.

Varices essentially never bleed until HVPG surpasses 12 mmHg — this threshold is the pivot of the whole disease and the target of therapy.

Clinical Presentation and Classic Signs

The textbook presentation is painless, massive hematemesis — vomiting of bright red blood or clots — accompanied by melena (black, tarry stool) or, with brisk bleeding, frank hematochezia. Unlike ulcer bleeds, variceal hemorrhage is typically not preceded by epigastric pain.

• Hemodynamic instability: tachycardia, hypotension, orthostasis, and shock reflect the volume lost.
• Stigmata of chronic liver disease: jaundice, spider angiomata, palmar erythema, gynecomastia, caput medusae (dilated periumbilical veins), splenomegaly, and ascites point to the underlying portal hypertension.
• Encephalopathy: the nitrogen load of digested blood in the gut can precipitate or worsen hepatic encephalopathy — confusion and asterixis may appear or deepen.

A critical clinical pitfall: any patient with known or suspected cirrhosis presenting with upper GI bleeding should be treated as a variceal bleed until endoscopy proves otherwise, because delay is what kills. The combination of hematemesis plus signs of chronic liver disease is the clinical gestalt that triggers the variceal-bleed protocol before the scope even confirms the source.

Diagnosis: Endoscopy, Gradients, and Risk Scores

Upper endoscopy (EGD) is both the diagnostic gold standard and the therapeutic tool. Guidelines recommend endoscopy within 12 hours of presentation once the patient is resuscitated. The endoscopist confirms the varix as the bleeding source and looks for high-risk stigmata:

• Red wale marks (longitudinal red streaks) and cherry-red spots — signs of imminent or recent rupture.
• Active spurting or oozing, an overlying platelet plug, or the classic white nipple sign marking the rupture point.
• Varix size (small vs. large/medium), used with red signs and Child–Pugh class to stratify bleeding risk.

The definitive hemodynamic measurement is HVPG via a balloon catheter in the hepatic vein. Key cutoffs: ≥10 mmHg defines clinically significant portal hypertension (Baveno VII); >12 mmHg is required for varices to bleed; and >20 mmHg measured early predicts treatment failure and death, flagging patients for pre-emptive TIPS. Non-invasively, liver stiffness ≤15 kPa plus platelets ≥150 ×10⁹/L rules out CSPH, while ≥25 kPa rules it in. Prognosis is scored with Child–Pugh and MELD.

Management at the Mechanism Level

Effective therapy attacks the pressure cascade from multiple angles simultaneously, plus airway/volume resuscitation. A restrictive transfusion strategy (target hemoglobin ~7 g/dL) is used because over-transfusion raises portal pressure and worsens rebleeding.

• Vasoactive drugs (start before endoscopy): Terlipressin (a vasopressin analog, V1-receptor agonist) or octreotide/somatostatin cause splanchnic arteriolar vasoconstriction, cutting portal inflow and dropping HVPG. Terlipressin is the only agent with a proven survival benefit; continue 2–5 days.
• Endoscopic variceal ligation (EVL): rubber bands strangulate the varix, causing thrombosis and obliteration — first-line and superior to sclerotherapy.
• Antibiotic prophylaxis: IV ceftriaxone 1 g/day reduces bacterial infection, rebleeding, and mortality — bacterial translocation is a key rebleed trigger.
• Rescue/definitive: TIPS creates a shunt that decompresses the portal system; balloon tamponade or an esophageal stent bridges to it. Pre-emptive TIPS within 72 h benefits high-risk patients (Child–Pugh C ≤13, or B with active bleeding).

Secondary prophylaxis combines a non-selective beta-blocker (propranolol/nadolol or carvedilol — reducing cardiac output and causing splanchnic vasoconstriction) with serial EVL.

Mimics, Pitfalls, and Significance

Not every upper GI bleed in a cirrhotic is variceal — roughly one-third have a non-variceal source. The key distinctions and traps:

• Gastric varices: often fed by splenic vein flow; bleed less often but more severely, and are treated differently (cyanoacrylate glue injection or BRTO, not standard banding).
• Portal hypertensive gastropathy: a diffuse mosaic mucosal oozing rather than a discrete varix — managed with beta-blockers, not banding.
• Peptic ulcer / Mallory–Weiss tear: common mimics; endoscopy differentiates them (see table).
• Splenic vein thrombosis causes isolated gastric varices with a normal-pressure portal system (left-sided/sinistral portal hypertension) — the cure is splenectomy, and giving beta-blockers here is the wrong move.

Do-not-miss pitfalls: forgetting antibiotics (a mortality-lowering intervention that is easy to skip), over-transfusing, ignoring airway protection before endoscopy in a vomiting encephalopathic patient, and mistaking sinistral portal hypertension for cirrhotic portal hypertension. The overarching significance: variceal bleeding is a sentinel event marking decompensated liver disease and should prompt evaluation for liver transplantation.

Upper GI bleeding in cirrhosis: variceal vs. common mimics

Feature	Esophageal variceal bleed	Peptic ulcer bleed	Mallory-Weiss tear
Underlying driver	Portal hypertension (HVPG >12 mmHg)	H. pylori / NSAIDs, acid injury	Forceful retching/vomiting
Bleeding character	Massive, painless, often torrential	Variable; may have epigastric pain	Self-limited in ~90%; after emesis
Endoscopic finding	Tortuous submucosal columns, red wale signs	Discrete ulcer with visible vessel	Longitudinal mucosal tear at GE junction
First-line therapy	Vasoactive drug + band ligation	Endoscopic clip/thermal + high-dose PPI	Supportive; endoscopy if persistent
Adjunct that saves lives	IV ceftriaxone prophylaxis	PPI infusion	Rarely needed
Definitive rescue	TIPS	Angioembolization / surgery	TIPS not applicable